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Abstract 38 
Context. Postprandial triglyceride (TG) concentration is independently associated with cardiovascular 39 
disease risk. Exercise reduces postprandial TG concentrations but the mechanisms responsible are 40 
unclear. 41 
Objective. To determine the effects of exercise on affinity of chylomicrons, large very low density 42 
lipoproteins (VLDL1) and smaller VLDL (VLDL2) for lipoprotein lipase (LPL) mediated TG 43 
hydrolysis. 44 
Design. Within-participant cross-over study  45 
Setting. A University metabolic investigation  unit. 46 
Participants. Ten overweight/obese men. 47 
Interventions. Participants undertook two oral fat tolerance tests, separated by 7-14 days, in which 48 
they had blood taken fasting and for 4 hours after a high-fat mixed meal.  On the afternoon before one 49 
test, they performed a 90-minute treadmill walk at 50% maximal oxygen uptake (EX); no exercise 50 
was performed before the control test (CON). 51 
Main outcome measures. Circulating TG-rich lipoprotein concentrations; affinity of chylomicrons, 52 
VLDL1, VLDL2 for LPL-mediated TG hydrolysis.  53 
Results. Exercise significantly reduced fasting VLDL1-TG concentration (CON: 0.49(0.33-0.72) 54 
mmol.l-1, EX: 0.36(0.22-0.59) mmol.l-1, [geometric means (95% confidence interval)]; p=0.04). Time-55 
averaged postprandial chylomicron-TG (CON: 0.55±0.10 mmol.l-1, EX: 0.39±0.08 mmol.l-1, 56 
[mean±SEM], p=0.03) and VLDL1-TG (CON: 0.85±0.13 mmol.l-1, EX: 0.66±0.10 mmol.l-1, p=0.01) 57 
concentrations were both lower in EX than CON.  Affinity of VLDL1 for LPL-mediated TG 58 
hydrolysis increased by 2.2(1.3-3.7) fold (geometric mean (95% confidence interval)) (p=0.02) in the 59 
fasted state and 2.6(1.8-2.6) fold (p=0.001) postprandially.  Affinity of chylomicrons and VLDL2 was 60 
not significantly different between trials. 61 
Conclusions. Exercise increases affinity of VLDL1 for LPL-mediated TG hydrolysis both fasting and 62 
postprandially.  This mechanism is likely to contribute to exercise’s TG-lowering effect.   63 
 64 
  65 
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Introduction 66 
Postprandial triglyceride (TG) concentrations are independently associated with risk of cardiovascular 67 
events (1-3) and implicated in the atherosclerotic disease process (4,5).  Recent Mendelian 68 
randomisation studies reasserted the likely causal role of TG-mediated pathways in cardiovascular 69 
disease (CVD) (6-9). Moderate intensity exercise lowers postprandial TG concentrations by ~15-25% 70 
in a range of population groups at increased risk of cardiovascular disease (10-12) and is 71 
recommended as a TG-lowering intervention for patients at high CVD risk (5). However, the 72 
mechanism(s) by which exercise lowers TG have not been fully elucidated.   73 
 74 
The exercise-induced reduction in postprandial TG concentration is quantitatively greater in very low 75 
density lipoproteins (VLDL) than in chylomicrons (13,14), with large VLDL particles (VLDL1, Sf 60-76 
400) being the lipoprotein subclass most affected (13).  Kinetic studies have shown that exercise-77 
induced VLDL-TG reductions are due to increased clearance from the circulation, rather than reduced 78 
hepatic production (15-17).  While exercise has also been shown to increase clearance of 79 
chylomicron-like particles (15,18,19), the magnitude of this change is smaller than the increase in 80 
clearance of VLDL1-TG (15), and the effect has not been consistently observed (20).  Furthermore, 81 
although exercise-induced reductions in postprandial TG concentrations are sometimes accompanied 82 
by an increase in post-heparin plasma or skeletal muscle lipoprotein lipase (LPL) activity, post-83 
exercise TG reductions are also commonly observed in the absence of increased LPL activity (21,22).  84 
The affinity of chylomicrons/chylomicron-like particles for LPL clearance is many fold greater than 85 
that of VLDL particles (23); thus the observation that exercise increases VLDL1-TG clearance to a 86 
greater extent than chylomicron-like particles (15), taken together with the inconsistent changes to 87 
LPL activity in response to exercise (21), suggest that mechanisms other than increased LPL activity 88 
are likely to contribute to the exercise-induced increase in VLDL1-TG removal.  There is evidence 89 
that circulating VLDL1 particles are larger and more TG enriched following exercise (13,15) – 90 
changes that might be expected to increase the affinity of these particles for LPL-mediated hydrolysis 91 
(24) – and we have recently demonstrated that these exercise-induced changes to the size and TG 92 
enrichment of circulating VLDL1 particles explain about half of the variance in the exercise-induced 93 
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increase in VLDL1 particle clearance in correlational analyses (15).  This observation is consistent 94 
with exercise-induced changes to VLDL1 particles increasing their affinity for LPL-mediated 95 
clearance (15,25): this data interpretation would also explain how exercise could increase clearance of 96 
VLDL1-TG without necessarily increasing LPL activity, and why the exercise-induced increase in 97 
VLDL1-TG clearance is quantitatively larger than that observed in chylomicron-like particles.  98 
However, the hypothesis that exercise increases the affinity of VLDL1 as a substrate for LPL has not 99 
been directly tested. The purpose of this study was therefore to determine the effects of exercise on 100 
the affinity of TG-rich lipoprotein species (chylomicrons, VLDL1, and VLDL2 (Sf 20-60)) for LPL-101 
mediated TG hydrolysis. 102 
 103 
Materials and Methods 104 
Participants. Ten overweight/obese men, aged 35.9±11.8 y (mean±SD), body mass 92.5±19.9 kg, 105 
body mass index (BMI) 30.4±5.4 kg.m-2, waist circumference 102.2±11.4 cm, and maximal oxygen 106 
uptake (VO2max) 36.5±11.8 ml.kg-1.min-1 participated in this study. All participants were apparently 107 
healthy, normotensive, normoglycemic, non-smokers.  None was taking any drugs known to affect 108 
lipid or carbohydrate metabolism.  The study was conducted in accord with the Declaration of 109 
Helsinki and approved by the University of Glasgow Ethics Committee.  All participants gave written 110 
informed consent. 111 
 112 
Study design. Participants attended the laboratory for two oral fat tolerance tests (OFTT) in random 113 
order with an interval of 7-14 days.  On the afternoon prior to one OFTT, participants walked on a 114 
treadmill at 50% VO2max for 90 minutes (Exercise trial: EX).  They performed no exercise (and did not 115 
attend the lab) on the day preceding the other OFTT (Control trial: CON).  Participants recorded their 116 
dietary intake and refrained from alcohol for the two days prior to the first OFTT, and replicated this 117 
prior to the second test.  They also performed no exercise, other than the treadmill walk in the 118 
exercise trial, during the three days preceding each OFTT. 119 
 120 
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Preliminary exercise test. At least one week prior the first OFTT, a preliminary sub-maximal 121 
incremental treadmill test  was undertaken to estimate VO2max  and determine the walking speed and 122 
gradient required to elicit 50% VO2max (26).   123 
 124 
Treadmill walk. In EX, the 90-minute treadmill walk was completed ~16-18 h before the OFTT: this 125 
time interval was chosen to reflect the time scale at which the maximal TG-lowering effects of 126 
exercise are evident (21).  Expired air samples were collected using Douglas bags to determine 127 
oxygen uptake (VO2) and carbon dioxide production, heart rate was measured (Polar Electroky, 128 
Kempele, Finland) and ratings of perceived exertion (27) were obtained at 15-minute intervals during 129 
the walk. 130 
  131 
Oral fat tolerance tests. Participants reported to the metabolic suite in the morning after an overnight 132 
12-hour fast.  A cannula was placed in an antecubital vein and, after a 10-minute interval, a blood 133 
sample was taken.  A test breakfast comprising a croissant with butter, and a meal-replacement drink 134 
(Complan, Complan Foods Ltd) made with whole milk and double cream, providing 92g fat, 68g 135 
carbohydrate, 25g protein and 1277kcal energy, was consumed and further blood samples were 136 
obtained 30, 60, 90, 120 and 240 minutes postprandially.  Participants rested and consumed only 137 
water during this time.  138 
 139 
Blood processing and storage. Blood samples were collected into potassium EDTA tubes and placed 140 
on ice.  Plasma was separated within 15 minutes of collection.  Plasma for lipoprotein separation was 141 
stored at 4°C until processing within 24 hours.  The remaining plasma was divided into aliquots and 142 
frozen at -80°C until analysis.   143 
 144 
Lipoprotein separation. Plasma samples (2ml) from 0, 120 and 240 minute time-points were 145 
ultracentrifuged to isolate chylomicron (Sf >400), VLDL1 and VLDL2 lipoprotein subfractions as 146 
previously described (28).  VLDL1 and VLDL2 fractions were assayed for cholesterol, free cholesterol 147 
(FC), TG, phospholipid (PL), protein and apolipoprotein B (apoB); VLDL1 and VLDL2 concentration 148 
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was calculated by summing the concentration of their components; and TG/apoB and CE/TG ratios 149 
were calculated as previously described (15).  Chylomicron fractions were assayed for TG.   150 
Coefficients of variation (CV) were: 2.9% for total cholesterol, 3.8% for TG, 2.2% for FC, 3.8% for 151 
PL, 13.2% for apoB and 3.0% for protein. 152 
 153 
Chylomicrons, VLDL1 and VLDL2 were concentrated in preparation for the LPL affinity assays. At 154 
the 240-minute time-point, 30ml plasma was ultracentrifuged to separate chylomicrons, which were 155 
then concentrated 8-10 fold by centrifugation for 60 minutes at 1,500 x g through a Centriprep® 156 
filtering tube.  Chylomicron-free plasma at the 240-minute time-point, and 30ml of plasma collected 157 
at 0-minute time-point, was then concentrated ~10-fold by ultracentrifugation before lipoprotein 158 
separation to obtain concentrated VLDL1 and VLDL2 fractions.  The lipoprotein fractions were 159 
adjusted to a TG concentration of 0.6mmol.l-1 by the addition of d 1.006g.ml-1 density solution. 160 
 161 
LPL affinity assays. Affinity of chylomicrons, VLDL1 and VLDL2 for LPL was determined using a 162 
modified version of a method described previously (29).  In brief, LPL from Pseudomonas sp. was 163 
prepared in a solution containing: 200mmol.l-1 Tris-HCl buffer, 130mmol.l-1 NaCl, 66.7mg.l-1 sodium-164 
heparin, and 3.3mmol.l-1 CaCl2 (all Sigma: Poole, UK), at pH 8.2, to give a final LPL activity of 165 
0.1units.ml-1.  For each assay, 70μl of lipoprotein fraction (at 0.6mmol.l-1 TG concentration) was 166 
incubated with 35μl of Tris-HCl buffer at 37°C for 10 minutes, before adding 35μl LPL solution, brief 167 
mixing by vortex and further incubation at 37Cº.  Separate tubes containing the lipoprotein fractions 168 
were incubated in the LPL solution for 0, 5, 10, 15, 20 and 30 minutes, before quenching the reaction 169 
by adding 93μl of ice-cold 5mol.l-1 NaCl, mixing, and placing the tube on ice for >5 minutes.  170 
Reactions were performed in triplicate, and two controls [No LPL and no lipoprotein (105μl 171 
1.006g.ml-1 density solution added), and LPL but no lipoprotein (70μl 1.006 g.ml-1 density solution 172 
added)] (incubated for 10 minutes) were included for each experiment.  Non-esterified fatty acid 173 
(NEFA) concentration was determined in each tube using commercially available kits (Wako 174 
Chemicals, USA, Inc.).  Affinity of lipoproteins for LPL was determined by the rate of NEFA release 175 
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over the linear portion of 30-minute incubation period before a plateau was achieved.  The CV for 176 
NEFA release from the LPL-lipoprotein reactions was 9.9% for chylomicrons and 15.1% for VLDL1.     177 
 178 
Plasma assays. Plasma glucose, TG (Randox Laboratories, Crumlin, UK), NEFA (Wako Chemicals) 179 
and small dense LDL (sdLDL) cholesterol (Denka Seiken, Tokyo, Japan) concentrations were 180 
analysed, using commercially available enzymatic and turbidimetric kits.  Insulin was measured in 181 
EDTA plasma using commercially available ELISA kits (Mercodia, Uppsala, Sweden).  In the fasted 182 
state, total and HDL cholesterol (Roche Diagnostics, Mannheim, Germany) were measured, and LDL 183 
cholesterol was calculated using the Friedewald equation (30).  CVs for assays not already mentioned 184 
above were: 2.0% for glucose, 5.2% for NEFA, 2.8% for HDL cholesterol, 6.3% for sdLDL 185 
cholesterol and <4% for insulin. 186 
  187 
Data analysis. Statistical analyses were performed using Statistica (version 10, StatSoft Inc.) and 188 
Minitab (version 17, Minitab Ltd).  Data were tested for normality using the Anderson-Darling test 189 
and, where they did not approximate a normal distribution, were log-transformed prior to analysis and 190 
expressed as geometric means with 95% confidence intervals (95% CI).   Time-averaged postprandial 191 
concentrations were used as summary measures of postprandial responses (11).  Paired t-tests were 192 
used to compare trials.  Differences in lipoprotein affinity for LPL were calculated for absolute (i.e. 193 
EX minus CON) and relative (fold) (i.e. EX divided by CON) changes.  An a priori power 194 
calculation, on the basis of our data for intra-subject reproducibility of postprandial TG responses in 195 
men, indicated that 10 participants would enable detection of a ~10% exercise-induced change in the 196 
TG response with 80% power (31).  Significance was accepted at p<0.05.  Data are presented as 197 
means±SEM unless otherwise stated. 198 
 199 
Results 200 
Treadmill walk.  Participants walked at 5.0±0.1 km.h-1 up a gradient of 5.6±0.9%.  All participants 201 
completed the 90-minute walk without difficulty, with perceived exertion of 10.8±0.4 (‘fairly light’) 202 
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on the Borg scale of 6–20 (27). Mean VO2  was 19.9±1.7 ml·kg−1·min−1 (51.9±1.5% VO2max), and 203 
mean heart rate was 125±3 beats.min-1.  Gross energy expenditure of the walk was 3.32±0.29 MJ. 204 
 205 
Plasma concentrations in the fasted and postprandial states. Table 1 shows fasting and time-206 
averaged postprandial plasma concentrations.  Fasting TG was 18% lower (p=0.04) and time-207 
averaged postprandial TG was 13% lower (p=0.03) in EX compared with CON.  sdLDL-cholesterol 208 
concentrations were lower in EX than CON both fasting and postprandially (p<0.001 for both).   209 
There were no significant differences between CON and EX for fasting or postprandial insulin, 210 
glucose or NEFA concentrations, or in fasting total, HDL or LDL cholesterol concentrations. 211 
 212 
Lipoprotein concentrations and composition in the fasted and postprandial states. Figure 1 shows 213 
fasting and postprandial chylomicron-TG, VLDL1-TG and VLDL2-TG concentrations.  Fasting 214 
chylomicron-TG concentrations were negligible in both trials (CON: 0.03±0.014 mmol.l-1, EX: 215 
0.02±0.005 mmol.l-1, p=0.25).  Exercise significantly reduced fasting VLDL1-TG (CON: 0.49(0.33-216 
0.72) mmol.l-1, EX: 0.36(0.22-0.59) mmol.l-1, geometric means (95% CI); p=0.04), but fasting 217 
concentration of VLDL2-TG did not differ between trials (CON: 0.21(0.12-0.36) mmol.l-1, EX: 218 
0.18(0.12-0.27) mmol.l-1, geometric means (95% CI); p=0.60).  Time-averaged postprandial 219 
chylomicron-TG concentrations (CON: 0.55±0.10 mmol.l-1, EX: 0.39±0.08 mmol.l-1, p=0.03) and 220 
time-averaged postprandial VLDL1-TG concentrations (CON: 0.85±0.13 mmol.l-1, EX: 0.66±0.10 221 
mmol.l-1, p=0.01) were both lower in the exercise compared with the control trial, but the time-222 
averaged postprandial VLDL2-TG concentration did not differ significantly between trials (CON: 223 
0.31±0.15 mmol.l-1, EX: 0.27±0.09 mmol.l-1, p=0.60). 224 
 225 
Table 2 shows total VLDL1 and VLDL2 concentration and the constituent lipoprotein molecules 226 
fasting and 240 minutes postprandially.  Total VLDL1 lipoprotein mass for was 24% lower fasting 227 
(p=0.04) and 17% lower postprandially (p=0.049) in EX compared to CON.  VLDL1 apo B 228 
concentrations were significantly lower fasting, but not postprandially, in EX than CON.  Both fasting 229 
and postprandial concentrations of VLDL1 TG, cholesteryl ester and free cholesterol were lower in 230 
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EX than CON.  Fasting VLDL1 TG/apo B ratio was 39% higher in EX compared to CON, but this 231 
was not statistically significant (p=0.09).  At 240 minutes, VLDL1 TG/apoB ratio was similar in the 232 
two trials.  Similarly, the fasting VLDL1 CE/TG ratio was 26% lower in EX than CON, but this 233 
difference was not statistically significant (p=0.16).  At 240 minutes VLDL1 CE/TG ratio was similar 234 
in the two trials.  No differences in VLDL2 concentration or composition were observed between 235 
trials. 236 
 237 
Lipoprotein affinity for LPL.  Figure 2 shows NEFA release over the 30-minute incubation period in 238 
the LPL-affinity assay for fasting and postprandial VLDL1 and VLDL2, and for postprandial 239 
chylomicrons in the two trials.  There was no significant change in affinity of chylomicrons for LPL 240 
expressed either as fold-change (1.2(0.6- 2.3) fold, p=0.59) or in absolute units (see Table 3).  241 
However, exercise increased VLDL1 affinity for LPL by 2.2(1.3-3.7) fold (geometric mean (95% CI)) 242 
in the fasted state (p=0.02 for fold increase; p-value for absolute increase shown in Table 3) and by 243 
2.6(1.8-3.8) fold in the postprandial state (p=0.001 for fold increase; p-value for absolute increase 244 
shown in Table 3).  Affinity of VLDL2 for LPL was negligible and did not change in response to 245 
exercise. In CON, affinity of chylomicrons for LPL was 11.3(6.0-21.6) fold greater (p=0.0001) than 246 
that of VLDL1 in the postprandial state, whereas in EX it was 6.0(3.0-12.0) greater (p=0.0007).   247 
There was no significant difference in affinity of VLDL1 for LPL between the fasted and postprandial 248 
states in either CON (p=0.18) or EX (p=0.28).    249 
 250 
Discussion 251 
The main novel finding of the present study is that prior exercise significantly increased the affinity of 252 
large VLDL1 – but not of chylomicrons or VLDL2 – for clearance by LPL.  These findings provide an 253 
important advance in our understanding of the mechanism by which exercise lowers TG 254 
concentrations and put previous observations in this field into context.  Earlier work demonstrated that 255 
exercise often lowered TG concentrations without substantially increasing post-heparin plasma or 256 
skeletal muscle LPL activity (21,22,32); that the TG reductions induced by exercise were typically 257 
larger in VLDL than chylomicrons (13,14); and that exercise increased clearance of VLDL from the 258 
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circulation, but did not reduce hepatic VLDL production (16,17).  However, these observations could 259 
not explain how this increased VLDL clearance could occur without a concomitant increase in LPL 260 
activity.   More recently, it was hypothesised that exercise may increase the affinity of VLDL1 for 261 
TG-hydrolysis by LPL (15,25), which received indirect support from observations that exercise 262 
upregulated clearance of VLDL1 to a greater extent than chylomicrons (15).  This hypothesis is 263 
confirmed by the present findings.  Exercise increased the affinity of VLDL1 for LPL clearance 2.2-264 
fold in the fasted state and 2.6-fold in the postprandial state, but did not significantly alter the affinity 265 
of chylomicrons.  Accordingly the affinity of VLDL1 relative to chylomicrons for LPL-mediated 266 
clearance in the postprandial state was ~2-fold greater in the exercise compared with the control trial.  267 
This is consistent with earlier observations that the exercise-induced increase in VLDL1-TG clearance 268 
was twice as great as the exercise-induced increase in chylomicron-like particles (15).     269 
 270 
In contrast to previous observations (13,15), we did not observe a statistically significant increase in 271 
size or TG-enrichment of VLDL1 particles after exercise in the present study.  However, this does not 272 
necessarily imply that exercise-induced changes to VLDL1 size and composition were unimportant in 273 
mediating the increase in affinity for LPL-mediated clearance.  Circulating VLDL1 particles are all 274 
essentially remnant particles, in that they will have had some LPL-mediated hydrolysis of their TG-275 
core by the time any blood sample is taken.  Post-exercise VLDL1 particles with greater affinity for 276 
LPL would have been exposed proportionately greater TG hydrolysis by the time blood was sampled.  277 
Thus, relative to newly secreted VLDL1 particles, circulating post-exercise VLDL1 particles may have 278 
had their size and TG-enrichment reduced to a greater extent than VLDL1 particles in the control trial.  279 
Thus, it is possible that following exercise, the liver produced larger, more TG-enriched VLDL1 280 
particles which contributed to an increased affinity for VLDL1, without this effect being reflected in 281 
the composition of the measured circulating VLDL1 particle (25).  This suggestion is supported by 282 
data from Magkos and colleagues who reported a reduction in hepatic VLDL-apoB100, but not 283 
VLDL-TG, secretion following exercise (17), implying secretion of a larger more TG-rich VLDL 284 
particle.  However, Al-Shayji and coworkers, who considered hepatic production of larger VLDL1 285 
particles, rather than total VLDL, found the ratio of VLDL1-TG production to VLDL1-apoB 286 
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production was similar in control and exercise trials, suggesting that the average size of the secreted 287 
VLDL1 particle may not have been influenced by exercise (15).  However, it is also important to 288 
recognise that VLDL1 particles are heterogeneous, occupying a greater than three-fold range in size 289 
and density, and thus considering only ‘average’ lipoprotein size and composition in the VLDL1 range 290 
may not reveal the whole story.  Interestingly, Al-Shayji et al reported a larger exercise-induced 291 
increase in the VLDL1-apoB fractional catabolic rate than the VLDL1-TG fractional catabolic rate 292 
(146% vs 82% increase) (15), suggesting that exercise was having a proportionately larger effect on 293 
clearance of smaller, less TG-rich VLDL1 particles (which have a lower TG/apoB ratio), either via 294 
direct particle removal or by TG-removal taking them out of the VLDL1 and into the VLDL2 density 295 
range.  This interpretation suggests that the observation that circulating VLDL1 particles post-exercise 296 
are larger and more TG-enriched reflects the fact that exercise disproportionately increased clearance 297 
of smaller, less TG-enriched particles at the lower end of the Sf 60-400 range, leaving proportionally 298 
more larger VLDL1 in the circulation.  Accordingly, it is possible that the strong correlations between 299 
change in VLDL1 apo B fractional catabolic rate and change in VLDL1 TG/apoB and CE/TG ratio 300 
previously observed (15) reflects greater clearance of smaller VLDL1 particles following exercise, 301 
which would have the net effect of increasing the average TG/apoB and CE/TG ratio of the remaining 302 
circulating lipoprotein particles in the VLDL1 density range.  This suggestion is supported by recent 303 
work from Harrison and colleagues who used nuclear magnetic resonance spectroscopy to quantify 24 304 
different VLDL subfractions in the fasted state following exercise (22).  They found that in response 305 
to exercise, there was a proportionally larger TG reduction in ‘medium VLDL’ (size range 43-55nm, 306 
approximately corresponding to Sf 100-200 (33), i.e. smaller VLDL1) than in ‘large VLDL’ (size (55-307 
260nm, approximately corresponding to Sf >200 (33), i.e. larger VLDL1), with VLDL particles over 308 
120nm in size being virtually unaffected by exercise (22).  The authors proposed that their findings 309 
were suggestive of independent metabolic regulation of different VLDL pools within the VLDL1 310 
range (22).  This is an attractive proposition which is consistent with our present and earlier (15) 311 
observations on the effects of exercise on VLDL1 metabolism.  Further study is needed to both 312 
examine the effects of exercise on the affinity of smaller and larger VLDL1 particles for LPL-313 
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mediated TG hydrolysis, and to understand the effects of exercise on TG and apoB kinetics of smaller 314 
and larger VLDL1 particles.   315 
 316 
This study evaluated the effects of exercise on the affinity of TG-rich lipoproteins for LPL-mediated 317 
clearance both fasting and postprandially, finding similar exercise-induced increases in VLDL1 318 
affinity under both conditions.  There are, however, two factors to consider when interpreting the 319 
postprandial data.  First, action of LPL on chylomicrons produces chylomicron remnant particles 320 
which fall into the Sf 60-400 range.  Thus, the isolated postprandial ‘VLDL1’ fraction contains both 321 
hepatically-produced VLDL1 particles and chylomicron remnants.  However, >95% of postprandial 322 
lipoprotein particles in this density range are apoB100 containing (i.e. hepatically-produced) (13), 323 
thus it seems unlikely that this relatively small ‘contamination’ from chylomicron remnants would 324 
have substantially influenced the results.   A further consideration is that in our in vitro assay, we 325 
assessed the affinity of isolated postprandial VLDL1 for LPL-mediated clearance without direct 326 
competition for chylomicrons, which does not fully reflect the in vivo system.  Thus, further study 327 
which assesses the effects of exercise on affinity of postprandial VLDL1 for LPL-mediated clearance 328 
in the presence of chylomicrons is warranted to extend the present findings. 329 
 330 
While this study clearly demonstrated that exercise increased the affinity of VLDL1 particles for 331 
clearance by LPL, this effect is unlikely to be solely responsible for the observed TG lowering effect.  332 
There was a significant reduction in chylomicron-TG concentration following exercise, which 333 
occurred without a statistically significant increase in chylomicron affinity for LPL-mediated 334 
clearance.  However, as the effect of exercise on chylomicron affinity for LPL-mediated clearance 335 
was quite variable, with some participants experiencing a >2-fold increase, it is possible that this 336 
contributed to the lowering of chylomicron-TG concentrations in a subset of individuals.  We did not 337 
measure post-heparin plasma or skeletal muscle LPL activity in the present study, so it is unclear 338 
whether this might have contributed to the lower chylomicron TG-concentrations.  However, previous 339 
studies have suggested that there is also considerable inter-individual variability in exercise-induced 340 
changes in LPL activity (34).  There is also evidence that exercise-induced changes in blood perfusion 341 
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to LPL-rich tissues – leading to increased interactions between chylomicron particles and LPL – is 342 
likely to contribute to the chylomicron-TG lowering effect (35,36).  Thus, it is possible that 343 
individually variable combinations of increased affinity of chylomicrons for LPL-mediated clearance, 344 
increased LPL activity, and increased blood flow all contributed to the reduction in chylomicron-TG 345 
concentration observed after exercise.  This is a testable hypothesis which warrants further 346 
investigation.   347 
 348 
A further observation was that exercise substantially reduced fasting and postprandial sdLDL 349 
cholesterol concentrations.  There is accumulating evidence that sdLDL have particularly high 350 
atherogenicity (37,38), thus, exercise-induced reductions are likely to have clinically relevant 351 
implications for CVD risk.  Elevated concentrations of TG-rich lipoproteins facilitate the development 352 
of sdLDL by accelerating CETP-mediated neutral lipid exchange, between TG-rich lipoproteins and 353 
LDL, leading to TG-enriched LDL particles, which are then acted on by hepatic lipase to produce 354 
sdLDL particles (37,38).  Thus, by lowering TG-rich lipoprotein concentrations, exercise is likely to 355 
have inhibited the neutral lipid exchange process leading to sdLDL formation.    356 
  357 
In conclusion, the main finding of this study was that exercise substantially increased the affinity of 358 
VLDL1 for LPL-mediated TG-hydrolysis both fasting and postprandially.  This provides an important 359 
piece in the jigsaw of understanding the effects of exercise on the metabolism of TG-rich lipoproteins.   360 
 361 
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Table 1. Fasting and postprandial plasma concentrations 
 
Fasting concentration Time-averaged postprandial concentration 
Control Exercise p-value Control Exercise p-value 
Plasma TG (mmol.l-1) 1.57 (1.18 to 2.08) 1.31 (0.98 to 1.74) 0.04* 2.72 ± 0.41 2.36 ± 0.31 0.03 
Glucose (mmol.l-1) 5.50 ± 0.22 5.47 ± 0.23 0.81 6.39 ± 0.46 6.35 ± 0.36 0.81 
Insulin (mU.l-1) 12.2 (6.1 to 24.2) 9.1 (6.1 to 13.6) 0.33* 93.5 ± 21.7 77.5 ± 19.9 0.23 
NEFA (mmol.l-1) 0.66 ± 0.06 0.73 ± 0.05 0.11 0.65 ± 0.06 0.64 ± 0.06 0.88 
3-hydroxybutyrate (mmol.l-1) 0.07 ± 0.02 0.12 ± 0.05 0.19 0.10 ± 0.03 0.08 ± 0.01 0.47 
Total cholesterol (mmol.l-1) 5.44 ± 0.33 5.49 ± 0.36 0.69    
HDL cholesterol (mmol.l-1) 1.06 ± 0.09 1.09 ± 0.10 0.38    
LDL cholesterol (mmol.l-1) 3.68 ± 0.28 3.83 ± 0.33 0.19    
Plasma small dense LDL (mmol.l-1) 1.40 ± 0.20 1.17 ± 0.17 0.0002 1.30 ± 0.16 1.15 ± 0.14 0.0006 
Values are mean ± SEM, n = 10. *Statistical analysis performed on log-transformed data and values are geometric mean (95% confidence interval),  
 
 
  
17 
 
Table 2. Concentration and composition of VLDL1 and VLDL2 in the fasted and postprandial states 
 
 
 
Fasting (0 minutes) Postprandial (240 minutes) 
  Control Exercise p-value Control Exercise p-value 
VLDL1 Total lipoprotein concentration (mg.dl-1) 84.1 ± 17.4 63.7 ± 13.0 0.04 137.9 ± 22.1 114.6 ± 18.0 0.049 
 Apo B (mg.dl-1) 1.98 ± 0.36 1.05 ± 0.21 0.01 2.22 ± 0.34 2.01 ± 0.31 0.33 
 Triglyceride (mg.dl-1) 51.7 ± 11.1 41.0 ± 8.9 0.04* 88.5 ± 14.0 73.9 ± 12.3 0.03 
 Cholesteryl ester (mg.dl-1) 7.7 ± 1.2 4.8 ± 3.0 0.03 11.6 ± 2.0 8.3 ± 1.2 0.048 
 Free cholesterol (mg.dl-1) 4.0 ± 0.9 2.6 ± 0.6 0.02 5.9 ± 1.1 4.6 ± 0.8 0.045 
 Phospholipid (mg.dl-1) 12.8 ± 3.0 9.2 ± 1.9 0.08 21.1 ± 3.7 17.6 ± 8.7 0.13 
 Protein (mg.dl-1) 8.0 ± 1.6 6.1 ± 1.1 0.12 10.8 ± 2.2 10.2 ± 1.2 0.73 
 TG/apoB ratio (mol:mol) 17751 ± 2507 24693 ± 4238 0.09 25103 ± 2304 23072 ± 2561 0.47 
 CE/TG ratio (mol:mol) 0.23 ± 0.03 0.17 ± 0.02 0.16 0.18 ± 0.02 0.16 ± 0.01 0.40 
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VLDL2 Total lipoprotein concentration (mg.dl-1) 49.5 ± 3.6 39.4 ± 2.2 0.15 38.2 ± 1.6 40.0 ± 2.8 0.59 
 Apo B (mg.dl-1) 4.00 ± 0.57 3.39 ± 0.17 0.50 2.43 ± 0.17 2.53 ± 0.15 0.60 
 Triglyceride (mg.dl-1) 18.2 ± 3.2 15.0 ± 2.5 0.29 15.8 ± 2.2 16.2 ± 2.3 0.83 
 Cholesteryl ester (mg.dl-1) 11.3 ± 3.0 9.1 ± 1.5 0.39 7.2 ± 1.5 6.7 ± 1.2 0.44 
 Free cholesterol (mg.dl-1) 4.0 ± 0.8 
3.3± 0.5 
 
0.22 3.0 ± 0.5 2.9 ± 0.4 0.56 
 Phospholipid (mg.dl-1) 9.8 ± 0.9 8.3 ± 0.5 0.36 7.3 ± 0.5 7.6 ± 0.6 0.70 
 Protein (mg.dl-1) 6.1 ± 0.4 3.7 ± 0.3 0.08 5.0 ± 0.2 6.6 ± 0.7 0.22 
 TG/apoB ratio (mol:mol) 3679 ± 567 3051 ± 400 0.19 5416 ± 993 4169 ± 540 0.20 
 CE/TG ratio (mol:mol) 0.59 ± 0.10 0.62 ± 0.06 0.79 0.45 ± 0.08 0.43 ± 0.04 0.78 
Values are mean ± SEM, n = 10. *Statistical analysis performed on log-transformed data 
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Table 3. Lipoprotein Affinity for LPL 
 NEFA release (mmol.min-1 per mmol lipoprotein per unit LPL activity) 
 
Fasting (0 minutes) Postprandial (240 minutes) 
Control Exercise p-value Control Exercise p-value 
Chylomicrons    1.25 (0.94 to 1.66) 1.52 (0.98 to 2.34) 0.53* 
VLDL1 0.16 (0.09 to 0.29) 0.35 (0.24 to 0.52) 0.018* 0.08 (0.03 to 0.19) 0.25 (0.15 to 0.42) 0.002* 
VLDL2 0.013 (0.004 to 0.044) 0.018 (0.007 to 0.049) 0.60 0.021 (0.006 to 0.070) 0.013 (0.004 to 0.048) 0.34 
Values are mean ± SEM, n = 10. *Statistical analysis performed on log-transformed data, and values are geometric mean (95% confidence interval) 
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Figure Legends 
Figure 1. Chylomicron-TG (top panel), VLDL1-TG (middle panel) and VLDL2-TG (bottom panel) 
concentrations in the fasted state (0 mins), and 120 and 240 minutes postprandially in the control and 
exercise trials.  Statistical analyses of these data is described in the results text. N = 10, Values are 
mean ± SEM.  
 
Figure 2. NEFA release over 30-minutes in LPL-affinity assay for chylomicrons in the postprandial 
state (top right), VLDL1 in the fasted (middle left) and postprandial (middle right) states and VLDL2 
in the fasted (middle left) and postprandial (middle right) states, in control and exercise trials.  N = 10, 
Values are mean ± SEM. Affinity of lipoproteins for LPL was determined by the rate of NEFA 
release over the linear portion of the 30-minute incubation period before a plateau was achieved for 
each individual participant.  Values for lipoprotein affinity for LPL and statistical analyses are shown 
in Table 3.   
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